XS1211044075 · Corp · EUR

Teva Pharmaceutical Finance Nether Regs 1.88% 2027/03

MID PRICE
115.02
par = 100
YIELD TO MAT.
3.78%
semi-annual
COUPON
1.880%
semi-annual · fixed
MATURITY
2027-03-31
bullet · 0.91y
OUTSTANDING
not disclosed
AS OF
2026-04-29
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
0.89 y
1bp ↑ ≈ -0.009% P&L
Convexity
1.23
higher = more curvature
Years to maturity
0.91 y
YTM source
Ingested
Fund disclosure
G-spread
+111 bps
vs ECB AAA curve · 2026-04-29
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Global High Yield Corporate Bond
iShares
Global HY Corporate$115K▼ $750.06%2026-04-29
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-29

Institutional footprint · signal-level holdings

0/ 100
Interpretation. Thin coverage — below signal threshold
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$115K
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
115,020 EUR
134,597 USD
FX SOURCE
ECB · CoinGecko
PRICE
115.02

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 1 7/8 03/31/27
FIGI
BBG0088L6HJ3
ISIN
XS1211044075
Type
Corp
Issued
2015-03-31
Face value
100 EUR
Ticker
TEVA 1.875 03/31/27
Sec. type
EURO-ZONE
Seniority
Senior Unsecured

Issuer curve

TEVA · 2 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.